BPG is committed to discovery and dissemination of knowledge
Case Control Study
Copyright: ©Author(s) 2026.
World J Diabetes. May 15, 2026; 17(5): 118141
Published online May 15, 2026. doi: 10.4239/wjd.v17.i5.118141
Table 1 Anthropometric and biochemical data of the study subjects, n (%)/mean ± SD
Observational index
Healthy control group (n = 58)
Type 2 diabetes mellitus group (n = 130)
Diabetic retinopathy group (n = 115)
P value
Male33 (57.90)81 (62.31)76 (66.09)0.479
Age (years)50.43 ± 12.5351.57 ± 11.2453.52 ± 10.870.191
Body mass index (kg/m2)22.29 ± 4.1822.98 ± 3.2523.12 ± 3.380.319
Diabetes duration (years)-8.00 (2.00, 14.25)12.00 (6.00, 18.00)< 0.001a
Family history of diabetes-25 (19.23)24 (20.87)0.749
History of diabetic retinopathy-5 (3.85)21 (18.26)< 0.001a
Systolic blood pressure (mmHg)113.30 ± 18.89120.79 ± 19.93128.11 ± 23.21< 0.001a
Diastolic blood pressure (mmHg)70.88 ± 4.5277.81 ± 9.1478.89 ± 10.57< 0.001a
Serum uric acid (μmol/L)335.92 ± 97.22351.10 ± 89.81353.00 ± 94.050.490
Total cholesterol (mmol/L)4.97 ± 0.874.58 ± 0.934.56 ± 1.330.045a
Triglycerides (mmol/L)1.36 ± 0.642.42 ± 1.982.46 ± 2.480.001a
Low-density lipoprotein cholesterol (mmol/L)2.93 ± 0.782.79 ± 0.822.68 ± 1.180.277
High-density lipoprotein cholesterol (mmol/L)1.53 ± 0.431.04 ± 0.291.02 ± 0.33< 0.001a
Serum 25-hydroxy vitamin D, nmol/L65.56 ± 12.7857.89 ± 18.8451.53 ± 21.81< 0.001a
Fasting plasma glucose (mmol/L)-7.85 ± 3.147.90 ± 2.960.898
Neutrophil-to-lymphocyte ratio1.52 ± 0.541.71 ± 0.731.93 ± 0.850.002a
Platelet-to-lymphocyte ratio107.35 ± 43.04112.84 ± 42.98127.26 ± 45.220.016a
Systemic immune-inflammation index331.91 ± 151.42376.17 ±194.71422.72 ± 263.500.029a


Write to the Help Desk